Concepedia

Amna Rizvi

AR

Statistics

Publications

1

Citations

151

H-Index

1

Active since

2023

Affiliations

Boise Kidney & Hypertension Institute(Current)

Amna Rizvi is an author at Boise Kidney & Hypertension Institute specializing in pharmacotherapy, chronic kidney disease, and nephrology.

Top concepts

Publications per year

2023–2023

1

Publications

1

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

, , +10

1–1 of 1